Inicio

Investigación e Informes

Informes técnicos, estudios y datos de mercado

Investigación e Informes
9 sept 2026•1 min de lectura
Oxford Study Links Shingles Vaccine to Reduced Heart Disease Risk
A large analysis of US electronic health records suggests the shingles vaccine may lower cardiovascular events, but researchers urge further clinical trials.
Investigación e Informes
9 sept 2026•1 min de lectura
Donggwang Pharma reduces Indenol 10 mg tablet size while keeping dosage
Donggwang Pharmaceutical has cut the diameter of its 10 mg propranolol tablet from 7 mm to 4.8 mm and halved its weight, keeping the same active ingredient amount, leading to patient questions.
Investigación e Informes
9 sept 2026•1 min de lectura
Virtual ‘Maumjaro’ Experience Mimics Obesity Drug Injection Online
A Korean online parody, ‘Maumjaro’, lets users simulate the injection process of the obesity drug Mounjaro without real medication.
Investigación e Informes
9 sept 2026•1 min de lectura
SeniGen Pursues AI‑Designed 2nd‑Gen Chimera Endolysin for Sepsis Treatment
SeniGen, known for food microbial diagnostics, is shifting to develop AI‑redesigned chimera endolysins targeting antibiotic‑resistant sepsis.
Investigación e Informes
9 sept 2026•1 min de lectura
BIRP Connect Showcases Pharma Data Productization at Tableau DataFam Seoul 2026
BIRP Connect, a subsidiary of Baro Pharm, presented its pharma data productization and analytics platform case at Tableau’s DataFam Seoul 2026 conference on the 20th.
Investigación e Informes
9 sept 2026•1 min de lectura
GC Green Cross teams with Osivax on next‑gen combined influenza vaccine
GC Green Cross and French vaccine firm Osivax have signed a strategic partnership to develop a combined influenza vaccine that merges GC’s existing flu shot with Osivax’s T‑cell‑based candidate OVX836.
Investigación e Informes
9 sept 2026•1 min de lectura
KDDF Concludes 2026 Science Conference on Translating Discoveries to Clinical Impact
The National New Drug Development Foundation wrapped up its 2026 KDDF Science Conference on Aug 27‑28 at Pyeongchang Alpensia Resort, focusing on science‑driven translation from discovery to patient benefit.
Investigación e Informes
9 sept 2026•1 min de lectura
Rhodiola Extract May Enhance Exercise Endurance, Study Shows
Research published in the Korean Pharmacist Journal suggests that pre‑exercise intake of Rhodiola rosea extract can improve endurance and overall performance.
Investigación e Informes
8 sept 2026•1 min de lectura
Robot-Assisted Knee Replacement Shows No Long-Term Benefit Over Conventional Surgery, Study Finds
A UK randomized trial of 339 patients found robot-assisted knee arthroplasty improves surgical precision but offers no significant advantage in pain, function, or recovery after one year.
Investigación e Informes
8 sept 2026•1 min de lectura
Medical Radiation Exams Reach 431.6 Million in 2025, CT Scans Drive Majority of Dose
Korea's disease control agency reports 431.6 M medical radiation exams in 2025, with CT comprising 3.8% of exams but 67.1% of radiation dose.
Investigación e Informes
7 sept 2026•1 min de lectura
Daewoong Pharma Secures USPTO Patent for eTurna Ionizable Lipid Technology
Daewoong Pharmaceutical announced that its ionizable lipid component of the eTurna LNP delivery platform has passed USPTO examination and received a patent registration decision, marking its first global patent after acquiring Turn Biotechnology's assets.
Investigación e Informes
7 sept 2026•1 min de lectura
Lundbeck Expands Use of Eversana AI Agency Platform Across US Commercial Ops
Lundbeck will broaden its partnership with Eversana, applying the AI Agency platform to marketing, medical communication and market access in the US.